Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-05

FDA Approved: RISPERIDONE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals' generic risperidone as an original application (ANDA214068).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

ORIG AP for RISPERIDONE (RISPERIDONE)